Melissa L. Johnson, MD, is now chief scientific officer while retaining leadership of lung cancer research, and Erika P. Hamilton, MD, is now chief development officer, late phase, while remaining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results